Skip to content
GLP-1 Scorecard
Menu
Graded #232

Zeuss

Zeuss is a multi-vertical telehealth platform offering compounded semaglutide and tirzepatide for weight loss alongside TRT, HRT, skin, and hair services.

Visit ZeussWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$125/mo (compounded)
Tirzepatide
$175/mo (compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Weigh Zeuss against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because Zeuss dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value85/100
Dose & formulation64/100
Clinical oversight55/100
Labs & monitoring52/100
Fulfillment67/100
Contract terms61/100

Strengths

  • One-time-purchase model with no subscription — genuinely rare among DTC GLP-1 providers
  • Publishes the FDA compounded-medication disclaimer
  • Names both 503A and 503B compounding pathways — uncommon transparency
  • Bundled pricing covers provider review, meds, and cold-chain shipping with no hidden fees
  • Full refund if a physician can't prescribe

Where it loses points

  • 503A pharmacy partner not named (only generic '503A and 503B state-licensed' framing)
  • LegitScript certification not mentioned
  • No named medical director or physician leadership
  • Full states-served list not disclosed
  • FDA issued Zeuss LLC dba Zeuss a warning letter in February 2026; the letter is public in FDA's warning-letter database

Bottom line — Grade C

Best for: Shoppers who want the only one-time-purchase, no-subscription compounded GLP-1 model.

Ranked #232 of 544 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

FDAWarning letter issued to Zeuss LLC dba Zeuss in February 2026. See the FDA warning-letter database.

Closest here

The rankings grading nearest Zeuss — the realistic shortlist.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Zeuss's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Zeuss's site. Not medical advice; see our disclosure.

← Back to the scorecard